Biotech Co. Nuredis Sued Over Board Members' Legal Costs
Investors in Nuredis Inc. on Monday filed a derivative suit asking the Delaware Chancery Court to bar the biotech company from paying legal costs for two board members they say duped them...To view the full article, register now.
Already a subscriber? Click here to view full article